Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer

Colorectal cancer (CRC) is the third most common malignancy in the world, with 22% of patients presenting with metastatic disease and a further 50% destined to develop metastasis. Molecular imaging uses antigen-specific ligands conjugated to radionuclides to detect and characterise primary cancer an...

Full description

Bibliographic Details
Main Authors: Tahleesa J. Cuda, Yaowu He, Thomas Kryza, Tashbib Khan, Brian W. Tse, Kamil A. Sokolowski, Cheng Liu, Nicholas Lyons, Madeline Gough, Cameron E. Snell, David K. Wyld, Stephen Rose, Andrew D. Riddell, Andrew R. L. Stevenson, Paul A. Thomas, David A. Clark, Simon Puttick, John D. Hooper
Format: Article
Language:English
Published: Hindawi-Wiley 2021-01-01
Series:Contrast Media & Molecular Imaging
Online Access:http://dx.doi.org/10.1155/2021/3153278

Internet

http://dx.doi.org/10.1155/2021/3153278

Similar Items